Bayer Aktiengesellschaft (WSE:BAY)
Poland flag Poland · Delayed Price · Currency is PLN
112.00
+3.34 (3.07%)
Aug 13, 2025, 5:57 PM CET
3.07%
Market Cap113.04B
Revenue (ttm)195.87B
Net Income (ttm)-14.50B
Shares Outn/a
EPS (ttm)-14.76
PE Ration/a
Forward PE5.74
Dividend0.47 (0.42%)
Ex-Dividend DateApr 28, 2025
Volume5
Average Volume99
Open112.00
Previous Close108.66
Day's Range112.00 - 112.00
52-Week Range78.97 - 132.50
Betan/a
RSI44.81
Earnings DateAug 6, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]

Sector Healthcare
Founded 1863
Employees 91,864
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BAY
Full Company Profile

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR Financial Statements

News

There is no news available yet.